FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Glipizide Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Teva Pharmaceuticals (New 05/28/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01) 05/28/2020 Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.
10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05) 05/28/2020 Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English